Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar;106(2):269-283.
doi: 10.1016/j.mcna.2021.11.004. Epub 2022 Feb 2.

Evaluation and Management of Secondary Hypertension

Affiliations
Review

Evaluation and Management of Secondary Hypertension

Harini Sarathy et al. Med Clin North Am. 2022 Mar.

Abstract

Hypertension is a major cause of cardiovascular morbidity and mortality globally. Many patients with hypertension have secondary causes of hypertension that merit further evaluation. For example, secondary hypertension can result in target organ damage to the heart, kidneys, and brain independent of the effects of blood pressure. Several causes benefit from targeted therapies to supplement first-line antihypertensive agents. However, secondary hypertension is often underrecognized. The goal of this review is to highlight optimal approaches to the diagnosis and management of common causes of secondary hypertension, including primary aldosteronism, renovascular hypertension, obstructive sleep apnea, and drug-induced hypertension.

Keywords: Blood pressure; Hypertension; Obstructive sleep apnea; Primary aldosteronism; Renal artery stenosis; Resistant hypertension; Secondary hypertension.

PubMed Disclaimer

Conflict of interest statement

Disclosure All authors report no relevant disclosures. Dr J.B. Cohen is supported by the National Institutes of HealthNational Heart, Lung, and Blood InstituteK23-HL133843 and R01-HL153646, National Center for Advancing Translational SciencesU01-TR003734, National Institute of Diabetes and Digestive and Kidney DiseasesR01-DK123104and U24-DK060990 and American Heart Association Bugher Award.

References

    1. Mills KT, Bundy JD, Kelly TN, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016;134(6):441–450. - PMC - PubMed
    1. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13–e115. - PubMed
    1. Byrd JB, Turcu AF, Auchus RJ. Primary Aldosteronism: Practical Approach to Diagnosis and Management. Circulation. 2018;138(8):823–835. - PMC - PubMed
    1. Monticone S, D'Ascenzo F, Moretti C, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6(1):41–50. - PubMed
    1. Funder JW, Carey RM, Mantero F, et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(5):1889–1916. - PubMed

MeSH terms

Substances